Isis Pharmaceuticals: what is the sense in antisense?

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.8, 1997-08, pp. : 813-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Making dollars and sense of antisense

By Wiggins Phillip

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 111-115

Informa Healthcare

Access to resources Recommend Favorite

ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1

By Shanahan W.R.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1417-1429

Informa Healthcare

Access to resources Recommend Favorite

Making sense of therapeutics using antisense technology

By Malik Ravinder Roy Ipsita

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 507-526

Informa Healthcare

Access to resources Recommend Favorite

Making Sense of AntisenseA New Approach to Cancer Therapy

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 2, 2003-01 ,pp. : 3-8

Adis International

Access to resources Recommend Favorite

Topical Delivery of Anti-sense Oligonucleotides Using Low-Frequency Sonophoresis

By Tezel Ahmet Dokka Sujatha Kelly Susan Hardee Gregory E. Mitragotri Samir

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2219-2225

Springer Publishing Company

Access to resources Recommend Favorite